Eli Lilly stock edges higher as company plans nearly $4 billion in vaccine deals

The deals are part of Eli Lilly’s effort to expand into infectious disease research and development.

# Eli Lilly stock edges higher as company plans nearly $4 billion in vaccine deals The deals are part of Eli Lilly’s effort to expand into infectious disease research and development. **Read the full article:** [CNBC](https://www.cnbc.com/2026/05/26/eli-lilly-stock-vaccine-deals-curevo-limmatech.html) *This article was originally published by CNBC. MoneyWiseInc provides expert curation of the best financial content from trusted sources.*